Ceva Overview
Company Headquarters: Lenexa, Kansas, US
Founded: 1988
Workforce: ~5500
Company Working: Ceva is a veterinary pharmaceutical company which is into top 10 veterinary health companies. The company operates through several business segments, including companion animals, cattle, poultry, small ruminants, and swine. The company develops and markets products related to reproduction management, anti-infectives treatment, and vaccines. Ceva has a presence in more than 45 countries and has 12 R&D centers and 25 production sites. The company operates in the Americas, Europe, Africa/Middle East, and Asia.
Strategy
CEVA's key strategy is to continue developing and licensing advanced processing and connectivity technologies to meet the growing demand for high-performance and energy-efficient solutions in key markets, such as 5G, artificial intelligence, and automotive. The company also aims to expand into new markets, such as IoT and smart homes, through strategic acquisitions and partnerships. Additionally, CEVA focuses on building strong partnerships with leading semiconductor companies and ecosystem players to increase market penetration and establish itself as a leading provider of licensable IP platforms and solutions. The company places a strong emphasis on innovation and customization to meet the unique needs of its customers and maintain its competitive edge in the rapidly evolving semiconductor industry.
